INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -6.7% | 19,203 | +35.4% | 0.00% | – |
| Q4 2021 | $75,000 | -6.2% | 14,181 | +42.0% | 0.00% | – |
| Q3 2021 | $80,000 | -96.0% | 9,985 | -95.6% | 0.00% | -100.0% |
| Q1 2021 | $2,001,000 | -15.1% | 227,398 | -12.3% | 0.00% | 0.0% |
| Q4 2020 | $2,357,000 | -74.7% | 259,361 | -65.5% | 0.00% | -75.0% |
| Q3 2020 | $9,329,000 | +1577.9% | 751,772 | +3049.2% | 0.01% | +700.0% |
| Q2 2020 | $556,000 | -29.9% | 23,872 | -77.4% | 0.00% | – |
| Q1 2020 | $793,000 | +1291.2% | 105,431 | +518.5% | 0.00% | – |
| Q4 2019 | $57,000 | +111.1% | 17,045 | +29.8% | 0.00% | – |
| Q3 2019 | $27,000 | +22.7% | 13,133 | +72.7% | 0.00% | – |
| Q2 2019 | $22,000 | +46.7% | 7,603 | +90.1% | 0.00% | – |
| Q1 2019 | $15,000 | -28.6% | 4,000 | -22.3% | 0.00% | – |
| Q4 2018 | $21,000 | -16.0% | 5,151 | +12.7% | 0.00% | – |
| Q3 2018 | $25,000 | +150.0% | 4,571 | +76.6% | 0.00% | – |
| Q2 2018 | $10,000 | -98.8% | 2,588 | -98.5% | 0.00% | -100.0% |
| Q1 2018 | $835,000 | -4.7% | 177,272 | -16.4% | 0.00% | 0.0% |
| Q4 2017 | $876,000 | -24.8% | 212,108 | +15.5% | 0.00% | 0.0% |
| Q3 2017 | $1,165,000 | +161.8% | 183,708 | +192.1% | 0.00% | – |
| Q4 2016 | $445,000 | -32.8% | 62,882 | -11.5% | 0.00% | – |
| Q3 2016 | $662,000 | -34.5% | 71,082 | -35.0% | 0.00% | -100.0% |
| Q2 2016 | $1,010,000 | +164.4% | 109,337 | +149.0% | 0.00% | – |
| Q1 2016 | $382,000 | +253.7% | 43,905 | +174.8% | 0.00% | – |
| Q4 2015 | $108,000 | +5300.0% | 15,975 | +4103.9% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 380 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 380 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 380 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | – | 380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |